The M-CSF receptor in osteoclasts and beyond.

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Colony-stimulating factor 1 receptor (CSF1R), also known as c-FMS, is a key receptor tyrosine kinase.
• CSF1R signaling, mediated by ligands like M-CSF and IL-34, is essential for myeloid cell survival, function, proliferation, and differentiation.
• This receptor is critical for various cell types, including osteoclasts, macrophages, microglia, and cells in the female reproductive tract and nervous system.

Purpose of the Study:

• To review recent advancements in understanding CSF1R's diverse roles in myeloid cells.
• To highlight the therapeutic potential of CSF1R inhibitors in disease management.
• To explore CSF1R's involvement in osteoclasts and other myeloid cell functions.

Main Methods:

• Literature review of recent research on CSF1R signaling pathways.
• Analysis of studies investigating the roles of CSF1R in various cell types and disease models.
• Examination of therapeutic strategies involving CSF1R inhibition.

Main Results:

• CSF1R signaling is crucial for the development and function of multiple myeloid cell lineages.
• Dysregulated CSF1R signaling is linked to inflammatory, neoplastic, and neurodegenerative diseases.
• Inhibitors targeting CSF1R kinase activity or blocking its signaling show therapeutic promise.

Conclusions:

• CSF1R plays a multifaceted role in cellular homeostasis and disease pathogenesis.
• Targeting CSF1R represents a viable therapeutic avenue for a range of debilitating conditions.
• Further research into CSF1R inhibitors could lead to novel treatment strategies.